Collaboration will leverage Flare Therapeutics' proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic compounds ...

He added: “My lab has shown that NO plays a major role in ASD. "However, this study emphasizes the critical role of this ...

Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

DOYLESTOWN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through ...

Transcription activation of genes by estrogens is driven by enhancers, which are often located within the same Topologically Associating Domain (TAD) as non-targeted promoters. We investigated how ...

APRIL, a leading skincare and fragrance chain in Israel, secures exclusive rights to Escentric Molecules, a gender-free ...

A Society of Plastics Engineers conference looked at the pace of change in finding alternatives to PFAS "forever chemicals" ...

JMP Securities initiated coverage of Instil Bio (TIL) with a Market Perform rating and no price target Instil Bio enters the :competitive ...

Click here for a full investment analysis of Cybin Inc., a speculative play on FDA approval for psychedelic-based treatments.